天堂国产午夜亚洲专区-少妇人妻综合久久蜜臀-国产成人户外露出视频在线-国产91传媒一区二区三区

當(dāng)前位置:主頁 > 醫(yī)學(xué)論文 > 眼科論文 >

高效表達(dá)RKIP基因?qū)θ撕眵[癌化療增敏作用的實(shí)驗(yàn)研究

發(fā)布時(shí)間:2018-04-15 09:20

  本文選題:喉癌 + RKIP。 參考:《吉林大學(xué)》2010年博士論文


【摘要】: 探討高效表達(dá)RKIP基因聯(lián)合化療藥物對(duì)人喉鱗癌細(xì)胞的作用,為喉癌基因聯(lián)合化療減低喉癌化療抵抗提供了理論依據(jù)。應(yīng)用DNA克隆技術(shù)構(gòu)建干涉和高效表達(dá)RKIP的重組質(zhì)粒,并進(jìn)行測(cè)序鑒定和效果鑒定;應(yīng)用真核細(xì)胞轉(zhuǎn)染技術(shù)將重組質(zhì)粒轉(zhuǎn)染人喉癌Hep-2細(xì)胞,觀察RKIP表達(dá)水平變化對(duì)喉鱗癌細(xì)胞增殖、周期、凋亡及侵襲的影響,并分析其作用機(jī)制;高效表達(dá)RKIP的重組質(zhì)粒聯(lián)合順鉑后,探討其減低喉癌化療抵抗和增強(qiáng)喉癌對(duì)順鉑敏感性的可能性。(1)經(jīng)酶切和測(cè)序證實(shí),成功構(gòu)建重組質(zhì)粒。熒光定量RT-PCR和Western印跡檢測(cè)RKIP mRNA和蛋白的表達(dá),高效表達(dá)組升高,干涉組表達(dá)降低,其中干涉組的RKIP-shRNA501抑制作用最為明顯。(2)MTT檢測(cè)結(jié)果顯示,高效表達(dá)組出現(xiàn)增殖抑制,干涉組出現(xiàn)增殖促進(jìn)。FCM檢測(cè)結(jié)果顯示,高效表達(dá)組的G1期細(xì)胞增多,出現(xiàn)明顯的凋亡峰。干涉組的G1期細(xì)胞減少,未出現(xiàn)明顯的凋亡峰。Matrigel侵襲實(shí)驗(yàn)結(jié)果顯示,高效表達(dá)組細(xì)胞侵襲力減弱,干涉組細(xì)胞侵襲力增強(qiáng)。MAPK通路的改變或許是RKIP引起喉鱗癌Hep-2細(xì)胞增殖、周期、凋亡、侵襲等改變的原因或部分原因。(3)高效表達(dá)RKIP的重組質(zhì)粒聯(lián)合順鉑后,MTT檢測(cè)結(jié)果顯示,細(xì)胞增殖受到明顯抑制。FCM檢測(cè)結(jié)果顯示,細(xì)胞凋亡明顯增強(qiáng),MAPK通路的改變或許是RKIP-pIRES2-EGFP增強(qiáng)DDP對(duì)喉鱗癌Hep-2細(xì)胞影響的原因或部分原因。高效表達(dá)RKIP基因聯(lián)合化療對(duì)人喉鱗癌具有顯著的治療效果。
[Abstract]:To investigate the effect of high expression of RKIP gene combined with chemotherapeutic drugs on human laryngeal squamous carcinoma cells, and to provide a theoretical basis for the combination of laryngeal oncogene and chemotherapy to reduce the chemotherapeutic resistance of laryngeal carcinoma.The recombinant plasmids expressing RKIP were constructed by DNA cloning, sequenced and identified, and the recombinant plasmids were transfected into human laryngeal carcinoma Hep-2 cells by eukaryotic cell transfection.To observe the effect of RKIP expression on proliferation, cell cycle, apoptosis and invasion of laryngeal squamous cell carcinoma cells, and to analyze its mechanism.To investigate the possibility of reducing chemotherapeutic resistance and enhancing the sensitivity of laryngeal carcinoma to cisplatin, the recombinant plasmid was successfully constructed by restriction endonuclease digestion and sequencing.Fluorescence quantitative RT-PCR and Western blotting were used to detect the expression of RKIP mRNA and protein. The expression of RKIP mRNA and protein increased in high expression group and decreased in intervention group. The inhibitory effect of RKIP-shRNA501 in intervention group was the most obvious. The results showed that proliferation inhibition appeared in high expression group.The results of proliferation-promoting. FCM assay showed that the G1 phase cells in the high expression group increased and the apoptotic peak appeared.In the intervention group, the G1 phase of cells decreased, and no obvious apoptotic peak. Matrigel invasion assay showed that the cell invasion of the high expression group was weakened, and the increase of the cell invasion and MAPK pathway in the intervention group might be due to the proliferation and cycle of Hep-2 cells induced by RKIP.The reason or part of apoptosis, invasion, etc.) the recombinant plasmid expressing RKIP efficiently combined with cisplatin showed that the cell proliferation was obviously inhibited.The effect of RKIP-pIRES2-EGFP on DDP in laryngeal squamous cell carcinoma (LSCC) might be due to the change of apoptosis.High expression of RKIP gene combined with chemotherapy has a significant therapeutic effect on human laryngeal squamous cell carcinoma.
【學(xué)位授予單位】:吉林大學(xué)
【學(xué)位級(jí)別】:博士
【學(xué)位授予年份】:2010
【分類號(hào)】:R739.65

【參考文獻(xiàn)】

相關(guān)期刊論文 前4條

1 李允光;濮德敏;劉雪梅;李艷麗;;RNAi沉默環(huán)氧合酶-2基因?qū)m頸癌Hela細(xì)胞細(xì)胞周期影響的實(shí)驗(yàn)研究[J];中華腫瘤防治雜志;2007年20期

2 康潔,劉福林;RNAi的抗病毒作用及其機(jī)制[J];現(xiàn)代免疫學(xué);2004年05期

3 Nicholas TRAKUL,Marsha R. ROSNER;Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein[J];Cell Research;2005年01期

4 于冬梅;郝立君;郭小英;李穎;羅賽;;人細(xì)胞周期蛋白cyclin D_1基因RNAi表達(dá)載體的構(gòu)建與鑒定[J];中國腫瘤;2007年12期



本文編號(hào):1753498

資料下載
論文發(fā)表

本文鏈接:http://www.sikaile.net/yixuelunwen/yank/1753498.html


Copyright(c)文論論文網(wǎng)All Rights Reserved | 網(wǎng)站地圖 |

版權(quán)申明:資料由用戶6cf50***提供,本站僅收錄摘要或目錄,作者需要?jiǎng)h除請(qǐng)E-mail郵箱bigeng88@qq.com